Free Trial

Oxbridge Re (OXBR) Competitors

Oxbridge Re logo
$1.57 +0.21 (+15.44%)
Closing price 03:55 PM Eastern
Extended Trading
$1.51 -0.06 (-3.82%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OXBR vs. HIT, ZBAO, AAME, FGF, HUIZ, CNFR, AIFU, TIRX, UNAM, and XHG

Should you be buying Oxbridge Re stock or one of its competitors? The main competitors of Oxbridge Re include Health In Tech (HIT), Zhibao Technology (ZBAO), Atlantic American (AAME), Fundamental Global (FGF), Huize (HUIZ), Conifer (CNFR), AIX (AIFU), Tian Ruixiang (TIRX), Unico American (UNAM), and XChange TEC.INC (XHG). These companies are all part of the "insurance" industry.

Oxbridge Re vs.

Oxbridge Re (NASDAQ:OXBR) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.

Health In Tech has higher revenue and earnings than Oxbridge Re.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxbridge Re$546K21.40-$9.91M-$0.43-3.65
Health In Tech$22.38M1.49N/AN/AN/A

Health In Tech's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxbridge ReN/A -114.38% -64.42%
Health In Tech N/A N/A N/A

5.6% of Oxbridge Re shares are held by institutional investors. 19.5% of Oxbridge Re shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Oxbridge Re received 197 more outperform votes than Health In Tech when rated by MarketBeat users.

CompanyUnderperformOutperform
Oxbridge ReOutperform Votes
197
42.18%
Underperform Votes
270
57.82%
Health In TechN/AN/A

Oxbridge Re currently has a consensus price target of $5.00, indicating a potential upside of 218.47%. Given Oxbridge Re's stronger consensus rating and higher probable upside, analysts plainly believe Oxbridge Re is more favorable than Health In Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxbridge Re
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Health In Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Oxbridge Re had 6 more articles in the media than Health In Tech. MarketBeat recorded 9 mentions for Oxbridge Re and 3 mentions for Health In Tech. Oxbridge Re's average media sentiment score of 0.97 beat Health In Tech's score of 0.47 indicating that Oxbridge Re is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxbridge Re
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Health In Tech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Oxbridge Re beats Health In Tech on 9 of the 12 factors compared between the two stocks.

Get Oxbridge Re News Delivered to You Automatically

Sign up to receive the latest news and ratings for OXBR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OXBR vs. The Competition

MetricOxbridge ReFire, marine, & casualty insurance IndustryFinance SectorNASDAQ Exchange
Market Cap$11.69M$48.77B$11.11B$7.93B
Dividend YieldN/A2.33%5.77%4.22%
P/E Ratio-1.8711.3622.1018.54
Price / Sales21.406.3226.31103.30
Price / CashN/A16.8117.6034.62
Price / Book1.732.262.674.25
Net Income-$9.91M$4.16B$1.03B$248.18M
7 Day Performance21.71%0.15%0.77%1.25%
1 Month Performance-18.74%-0.29%-0.17%3.76%
1 Year Performance42.92%19.62%538.56%5.28%

Oxbridge Re Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OXBR
Oxbridge Re
2.5971 of 5 stars
$1.57
+15.4%
$5.00
+218.5%
+27.7%$11.69M$546,000.00-1.873Upcoming Earnings
Analyst Forecast
Short Interest ↓
News Coverage
HIT
Health In Tech
N/A$0.68
-0.7%
N/AN/A$37.16M$22.38M0.0079
ZBAO
Zhibao Technology
N/A$1.02
+10.1%
N/A-66.9%$32.15M$245.79M0.00148Short Interest ↑
Gap Down
High Trading Volume
AAME
Atlantic American
1.0445 of 5 stars
$1.33
-4.2%
N/A-24.2%$27.14M$188.23M-3.80140Gap Down
FGF
Fundamental Global
1.089 of 5 stars
$15.99
-0.1%
N/A-50.7%$20.34M$28.64M12.219Short Interest ↑
HUIZ
Huize
1.32 of 5 stars
$1.82
+1.1%
N/A-86.9%$18.10M$1.25B20.221,640Short Interest ↓
CNFR
Conifer
1.5923 of 5 stars
$0.60
+0.3%
N/A-22.2%$7.38M$66.30M0.25150Gap Up
AIFU
AIX
N/A$0.13
+0.9%
N/AN/A$7.26M$2.36B0.185,780
TIRX
Tian Ruixiang
0.7717 of 5 stars
$1.37
+2.2%
N/A-44.9%$993,000.00$3.22M0.0050Upcoming Earnings
Short Interest ↑
UNAM
Unico American
N/A$0.07
-13.7%
N/A+250.0%$430,000.00N/A0.0040Gap Down
High Trading Volume
XHG
XChange TEC.INC
N/A$0.13
-2.2%
N/AN/A$42,000.00$288.37M0.0030Short Interest ↑
News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:OXBR) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners